⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246036 | 0.71 | — | — | |
| SCHEMBL10403739 | 0.69 | — | — | |
| SCHEMBL9193697 | 0.69 | — | — | |
| SCHEMBL6682908 | 0.69 | — | — | |
| SCHEMBL18671504 | 0.69 | — | — | |
| SCHEMBL8927719 | 0.69 | — | — | |
| SCHEMBL1843588 | 0.69 | — | — | |
| SCHEMBL8783208 | 0.65 | — | — | |
| SCHEMBL4141451 | 0.65 | — | — | |
| Ethylene Glycol SCHEMBL22712649 | 0.63 | TSHR (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4135683-A1 | THERAPEUTIC USE OF PLEUROMUTILINS | Nabriva Therapeutics GMBH (AT) | 2023-02-22 | — | — | EP | claimed |
| WO-2021209596-A1 | THERAPEUTIC USE OF PLEUROMUTILINS | Nabriva Therapeutics GmbH (AT) | 2021-10-21 | — | — | WO | claimed |
| CN-101089051-B | Epsilon-copper phthalocyanine, and its making method and coloring combination | TOYO INK MFG CO | 2015-04-01 | — | — | CN | disclosed |